Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer

被引:16
作者
Davis, BJ
Pisansky, TM
Leibovich, BC
机构
[1] Mayo Clin & Mayo Fdn, Div Radiat Oncol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA
关键词
prostatic neoplasms; radiation therapy; prostatectomy;
D O I
10.1097/00042307-200303000-00006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The use of adjuvant radiation therapy following prostatectomy is commonplace. The purpose of this review is to summarize completed and ongoing clinical trials and to review recent relevant studies and debates related to this subject. Recent findings The routine use of adjuvant radiation therapy remains a controversial topic. Recent retrospective matched-pair analyses support its use in appropriately selected patients with positive margins, extraprostatic extension or seminal vesicle invasion, but interpretation of these and other data vary. Although the 5-year biochemical recurrence rate using adjuvant radiotherapy may be decreased from approximately 40 to 10% in patients with either positive margins or extraprostatic extension, its effect on cause-specific mortality is unclear. Two prospective randomized trials with cumulative enrollment of over 1400 patients have examined the role of adjuvant radiation therapy compared with observation following prostatectomy: one trial was a National Cancer Institute-sponsored Intergroup study coordinated by the Southwest Oncology Group, and the other was from the European Organization for Research and Treatment of Cancer. Currently, the Radiation Therapy Oncology Group is conducting a three-arm trial, with broadened stratification criteria as compared with previous trials. This ongoing trial examines the use of adjuvant radiotherapy with or without adjuvant androgen deprivation following prostatectomy and also androgen deprivation alone in patients at high risk for disease relapse. Summary In lieu of data from completed randomized trials, indications for immediate adjuvant radiation therapy following prostatectomy exist and are supported by retrospective data with respect to reducing local and biochemical recurrence rates. However, data demonstrating an overall or cause-specific survival advantage for adjuvant radiotherapy as compared with delayed salvage therapy do not exist.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 47 条
[1]   Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued rise of biochemical failure after 5 years [J].
Amling, CL ;
Blute, ML ;
Bergstralh, EJ ;
Seay, TM ;
Slezak, J ;
Zincke, H .
JOURNAL OF UROLOGY, 2000, 164 (01) :101-105
[2]   Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen [J].
Anscher, MS .
INTERNATIONAL JOURNAL OF CANCER, 2001, 96 (02) :91-93
[3]   MULTIVARIATE-ANALYSIS OF FACTORS PREDICTING LOCAL RELAPSE AFTER RADICAL PROSTATECTOMY - POSSIBLE INDICATIONS FOR POSTOPERATIVE RADIOTHERAPY [J].
ANSCHER, MS ;
PROSNITZ, LR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (04) :941-947
[4]   Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: Effect on erectile function [J].
Bastasch, MD ;
Teh, BS ;
Mai, WY ;
Carpenter, LS ;
Lu, HH ;
Chiu, JK ;
Woo, SY ;
Grant, WH ;
Miles, BJ ;
Kadmon, D ;
Butler, EB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01) :101-106
[5]   QUANTITATIVE CLINICAL RADIOBIOLOGY [J].
BENTZEN, SM .
ACTA ONCOLOGICA, 1993, 32 (03) :259-275
[6]   Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy [J].
Blute, ML ;
Bergstralh, EJ ;
Iocca, A ;
Scherer, B ;
Zincke, H .
JOURNAL OF UROLOGY, 2001, 165 (01) :119-125
[7]   Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate [J].
Catton, C ;
Gospodarowicz, M ;
Warde, P ;
Panzarella, T ;
Catton, P ;
McLean, M ;
Milosevic, M .
RADIOTHERAPY AND ONCOLOGY, 2001, 59 (01) :51-60
[8]   Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: To irradiate or not? [J].
Choo, R ;
Hruby, G ;
Hong, J ;
Hong, E ;
DeBoer, G ;
Danjoux, C ;
Morton, G ;
Klotz, L ;
Bhak, E ;
Flavin, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :674-680
[9]   Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy [J].
Coetzee, LJ ;
Hars, V ;
Paulson, DF .
UROLOGY, 1996, 47 (02) :232-235
[10]   Postoperative radiotherapy for carcinoma of the prostate - Impact on both local control and distant disease-free survival [J].
Do, LV ;
Do, TM ;
Smith, R ;
Parker, RG .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (01) :1-8